logo

Analyzing the Impact of Earnings Reports on Brainstorm Cell Therapeutics, Inc Inc. (BCLI) Price Performance

Depending on how one views it, the stock price performance for the year has been a mixed bag, resulting in either an optimistic or pessimistic outlook. The index has shown a price loss of -31.29% this year. Over the last six months, there has been a weaker performance of 33.31%. The price of BCLI fallen by 78.05% during the last 30 days period. For the last 5-days stocks have improved 27.84%.

Brainstorm Cell Therapeutics, Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $10.05 on 05/22/24 and a low of $0.72 for the same time frame on 04/16/25.

52-week price history of BCLI Stock

Examining the 52-week high and low prices can provide valuable insights into a stock’s current status and future performance. Brainstorm Cell Therapeutics, Inc’s current trading price is -84.48% away from its 52-week high, while its distance from the 52-week low is 115.64%. The stock’s price range during this time has been between $0.72 and $10.05. The trading volume for the Healthcare sector company’s shares reached about 52.04 million for the day, which was higher than the average daily volume of 0.17 million over the last three months.

Market Capitalization vs. Financial Performance: A Comparative Study

Brainstorm Cell Therapeutics, Inc (BCLI) has experienced a quarterly decline of -15.23% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 12.38M and boasts a workforce of 27 employees.

Combining Moving Average and Trading Volume Data for Better Market Insight

Based on Barchart.com data, the company’s moving average over the 100-day period was 1.5720, with a change in price of -0.7100. Similarly, Brainstorm Cell Therapeutics, Inc recorded 645,673 in trading volume during the last 100 days, posting a change of -31.14%.

BCLI Stock Stochastic Average

Today’s raw stochastic average for Brainstorm Cell Therapeutics, Inc over the last 50 days is 70.75%.This indicates a increase from the raw stochastic average of the past 20 days, which was 68.83%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 71.36% and 68.41%, respectively.

Most Popular